SoftOx Solutions AS
SoftOx Solutions AS, together with its subsidiaries, operates as a clinical-stage pharmaceutical company that develops antimicrobials products for infection prevention and treatment in Norway. The company develops SoftOx Inhalation Solution, an inhalation solution that is phase II clinical trial for the treatment of ventilator associated pneumonia and other airway infections. It also developing p… Read more
SoftOx Solutions AS (SOFTX) - Net Assets
Latest net assets as of September 2025: Nkr100.26 Million NOK
Based on the latest financial reports, SoftOx Solutions AS (SOFTX) has net assets worth Nkr100.26 Million NOK as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Nkr117.52 Million) and total liabilities (Nkr17.26 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Nkr100.26 Million |
| % of Total Assets | 85.31% |
| Annual Growth Rate | 57.76% |
| 5-Year Change | 24.88% |
| 10-Year Change | N/A |
| Growth Volatility | 1286.56 |
SoftOx Solutions AS - Net Assets Trend (2016–2024)
This chart illustrates how SoftOx Solutions AS's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for SoftOx Solutions AS (2016–2024)
The table below shows the annual net assets of SoftOx Solutions AS from 2016 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | Nkr95.18 Million | +3922.42% |
| 2023-12-31 | Nkr2.37 Million | -85.22% |
| 2022-12-31 | Nkr16.01 Million | -81.99% |
| 2021-12-31 | Nkr88.85 Million | +16.57% |
| 2020-12-31 | Nkr76.22 Million | -11.85% |
| 2019-12-31 | Nkr86.47 Million | +500.12% |
| 2018-12-31 | Nkr14.41 Million | -46.33% |
| 2017-12-31 | Nkr26.85 Million | +982.03% |
| 2016-12-31 | Nkr2.48 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to SoftOx Solutions AS's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 0.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Nkr39.03 Million | 41.00% |
| Other Components | Nkr56.16 Million | 59.00% |
| Total Equity | Nkr95.18 Million | 100.00% |
SoftOx Solutions AS Competitors by Market Cap
The table below lists competitors of SoftOx Solutions AS ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Lokum Deweloper SA
WAR:LKD
|
$12.64 Million |
|
Artificial Intelligence Technology Solutions Inc
PINK:AITX
|
$12.64 Million |
|
SKB Shutters Corporation Bhd
KLSE:7115
|
$12.64 Million |
|
Eversendai Corporation Bhd
KLSE:5205
|
$12.64 Million |
|
CHINA NEW ENERGY LS-00025
F:9H5
|
$12.63 Million |
|
Mitrabara Adiperdana PT
JK:MBAP
|
$12.63 Million |
|
OpGen Inc
PINK:OPGN
|
$12.63 Million |
|
United Express Inc
PINK:UNXP
|
$12.63 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in SoftOx Solutions AS's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 2,366,350 to 95,184,540, a change of 92,818,190 (3922.4%).
- Net loss of 42,944,430 reduced equity.
- Share repurchases of 35,744,560 reduced equity.
- New share issuances of 35,744,555 increased equity.
- Other factors increased equity by 135,762,625.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Nkr-42.94 Million | -45.12% |
| Share Repurchases | Nkr35.74 Million | -37.55% |
| Share Issuances | Nkr35.74 Million | +37.55% |
| Other Changes | Nkr135.76 Million | +142.63% |
| Total Change | Nkr- | 3922.42% |
Book Value vs Market Value Analysis
This analysis compares SoftOx Solutions AS's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.51x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 0.11x to 1.51x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | Nkr0.66 | Nkr0.07 | x |
| 2017-12-31 | Nkr7.07 | Nkr0.07 | x |
| 2018-12-31 | Nkr3.81 | Nkr0.07 | x |
| 2019-12-31 | Nkr11.16 | Nkr0.07 | x |
| 2020-12-31 | Nkr9.15 | Nkr0.07 | x |
| 2021-12-31 | Nkr8.59 | Nkr0.07 | x |
| 2022-12-31 | Nkr1.55 | Nkr0.07 | x |
| 2023-12-31 | Nkr0.06 | Nkr0.07 | x |
| 2024-12-31 | Nkr0.05 | Nkr0.07 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently SoftOx Solutions AS utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -45.12%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -542.64%
- • Asset Turnover: 0.07x
- • Equity Multiplier: 1.27x
- Recent ROE (-45.12%) is above the historical average (-299.67%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | -250.51% | -6153.87% | 0.01x | 3.57x | Nkr-6.46 Million |
| 2017 | -35.04% | -940827.00% | 0.00x | 1.16x | Nkr-12.09 Million |
| 2018 | -89.73% | -299.06% | 0.18x | 1.62x | Nkr-14.37 Million |
| 2019 | -18.89% | -398.54% | 0.04x | 1.21x | Nkr-24.98 Million |
| 2020 | -49.08% | -380.17% | 0.11x | 1.15x | Nkr-45.03 Million |
| 2021 | -97.12% | -1092.14% | 0.07x | 1.21x | Nkr-95.17 Million |
| 2022 | -444.47% | -1000.07% | 0.09x | 4.86x | Nkr-72.74 Million |
| 2023 | -1667.07% | -565.17% | 0.07x | 41.09x | Nkr-39.69 Million |
| 2024 | -45.12% | -542.64% | 0.07x | 1.27x | Nkr-52.46 Million |
Industry Comparison
This section compares SoftOx Solutions AS's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $72,770,662
- Average return on equity (ROE) among peers: -85.32%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| SoftOx Solutions AS (SOFTX) | Nkr100.26 Million | -250.51% | 0.17x | $12.63 Million |
| Arctic Bioscience AS (ABS) | $287.28 Million | -11.84% | 0.14x | $3.71 Million |
| Aqua Bio Technology ASA (ABTEC) | $8.32 Million | -176.71% | 0.95x | $7.08 Million |
| Arcticzymes Technologies ASA (AZT) | $68.08 Million | -30.08% | 0.26x | $76.32 Million |
| Circa Group AS (CIRCA) | $41.74 Million | -16.77% | 0.13x | $3.57 Million |
| Circio Holding ASA (CRNA) | $-98.54 Million | 0.00% | 0.00x | $16.90 Million |
| Exact Therapeutics AS (EXTX) | $42.24 Million | -35.10% | 0.23x | $3.19 Million |
| Lytix Biopharma AS (LYTIX) | $107.89 Million | -87.37% | 0.36x | $32.31 Million |
| PCI Biotech Holding ASA (PCIB) | $57.40 Million | -95.98% | 0.11x | $432.13K |
| Thor Medical ASA (TRMED) | $140.52 Million | -314.06% | 1.11x | $48.68 Million |